[1]
R. Tuna Doğrul et al., “Can Syndecan-1 Be Used As A Biomarker In Alzheimer’s Disease?”, Acta Medica, vol. 53, no. 2, pp. 166–172, Jun. 2022, doi: 10.32552/2022.ActaMedica.729.